Macular Edema

• 

  Subject Areas on Research

  • A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema. 
  • A centrifugal fluidic immunoassay for ocular diagnostics with an enzymatically hydrolyzed fluorogenic substrate. 
  • A direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy. 
  • A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection. 
  • A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. 
  • A spreadsheet template for the analysis of optical coherence tomography in the longitudinal management of diabetic macular edema. 
  • Adverse events after intravitreal triamcinolone in patients with and without uveitis. 
  • Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema. 
  • Aflibercept for central retinal vein occlusion: an ongoing revolution or are we spinning in place? 
  • Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. 
  • Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema. 
  • Aldosterone Exposure Causes Increased Retinal Edema and Severe Retinopathy Following Laser-Induced Retinal Vein Occlusion in Mice. 
  • An anomaly detection approach for the identification of DME patients using spectral domain optical coherence tomography images. 
  • An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema. 
  • An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone. 
  • Analysis of pars plana vitrectomy for optic pit-related maculopathy with intraoperative optical coherence tomography: a possible connection with the vitreous cavity. 
  • Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials. 
  • Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema. 
  • Application of rapid scanning retinal thickness analysis in retinal diseases. 
  • Arcuate Retinal Nerve Fiber Layer Defect After Laser Photocoagulation for Diabetic Macular Edema. 
  • Association Between Perceived Barriers to Diabetes Self-management and Diabetic Retinopathy in Asian Patients With Type 2 Diabetes. 
  • Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. 
  • Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis. 
  • Association of Disorganization of Retinal Inner Layers With Visual Acuity In Eyes With Uveitic Cystoid Macular Edema. 
  • Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time. 
  • Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time. 
  • Association of Uveitis and Macular Edema With Anastrozole Therapy. 
  • Association of fluorescein angiographic features with visual acuity and with optical coherence tomographic and stereoscopic color fundus photographic features of diabetic macular edema in a randomized clinical trial. 
  • Association of the extent of diabetic macular edema as assessed by optical coherence tomography with visual acuity and retinal outcome variables. 
  • BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY. 
  • Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4. 
  • Best practices for treatment of retinal vein occlusion. 
  • Cataract Surgery Complexity and Surgical Complication Rates Among Medicare Beneficiaries With and Without Dementia. 
  • Characteristics of Branch Retinal Vein Occlusion in African American Patients. 
  • Characterization of Ebola Virus-Associated Eye Disease. 
  • Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion. 
  • Classification of SD-OCT volumes with multi pyramids, LBP and HOG descriptors: application to DME detections. 
  • Combination therapy for macular edema secondary to retinal vein occlusion. 
  • Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone. 
  • Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis. 
  • Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial. 
  • Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective. 
  • Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. 
  • Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application. 
  • Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. 
  • Conjunctival necrosis following the administration of subconjunctival corticosteroid. 
  • Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments. 
  • Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies. 
  • Correspondence. 
  • Current and Emerging Treatment for Diabetic Macular Edema. 
  • Current concepts in the management of central retinal vein occlusion. 
  • Current epidemiology of diabetic retinopathy and diabetic macular edema. 
  • Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. 
  • Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. 
  • Diabetic Retinopathy and Macular Edema Quality-of-Life Item Banks: Development and Initial Evaluation Using Computerized Adaptive Testing. 
  • Diabetic macular edema: Evidence-based management. 
  • Diabetic macular edema: what is focal and what is diffuse? 
  • Diabetic macular oedema: evidence-based treatment recommendations for Asian countries. 
  • Diabetic retinopathy. 
  • Diagnosis and Management of Idiopathic Persistent Iritis after Cataract Surgery (IPICS). 
  • Diagnostic and Therapeutic Challenges. 
  • Diagnostic methods for macular edema. 
  • Differential association of serum lipids with diabetic retinopathy and diabetic macular edema. 
  • Differential effects of triamcinolone and bevacizumab in central retinal vein occlusion. 
  • Differentiation of Diabetic Macular Edema From Pseudophakic Cystoid Macular Edema by Spectral-Domain Optical Coherence Tomography. 
  • Dilated retinal large vessels and capillaries associated with diabetic macular edema and photoreceptor loss respectively. 
  • Disappearance of myelinated retinal nerve fibers after pars plana vitrectomy. 
  • Discontinuation and loss to follow-up rates in clinical trials of intravitreal anti-vascular endothelial growth factor injections. 
  • Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema. 
  • Dynamics of human foveal development after premature birth. 
  • Early macular morphological changes following plaque radiotherapy for uveal melanoma. 
  • Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. 
  • Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial. 
  • Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. 
  • Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial. 
  • Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema. 
  • Effect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusion. 
  • Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. 
  • Effects of Long-Term DME Control With 0.2 µg/Day Fluocinolone Acetonide Implant on Quality of Life: An Exploratory Analysis From the FAME Trial. 
  • Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. 
  • Electron immunocytochemical analysis of posterior hyaloid associated with diabetic macular edema. 
  • Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections. 
  • FUNCTIONAL OUTCOMES OF YOUNG INFANTS WITH AND WITHOUT MACULAR EDEMA. 
  • Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study). 
  • Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. 
  • Fluorescein Angiographic Characteristics of Macular Edema During Infancy. 
  • Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular Edema. 
  • Fully automatic segmentation of fluorescein leakage in subjects with diabetic macular edema. 
  • Fully automatic software for retinal thickness in eyes with diabetic macular edema from images acquired by cirrus and spectralis systems. 
  • HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy. 
  • Identification of patients with diabetic macular edema from claims data: a validation study. 
  • Impact and Implication of Fovea-Involving Intraretinal Hemorrhage after Acute Branch Retinal Vein Occlusion. 
  • Impact of diabetic retinopathy on vision-specific function. 
  • Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. 
  • Improvement of Recalcitrant Diabetic Macular Edema After Peritoneal Dialysis. 
  • Improving Outcomes for Patients With Diabetic Macular Edema. 
  • Individuals' Perspectives on Coping with Vision Loss from Diabetic Retinopathy. 
  • Interobserver variability in optical coherence tomography for macular edema. 
  • Interpreting thickness changes in the diabetic macula: the problem of short-term variation in optical coherence tomography-measured macular thickening (an american ophthalmological society thesis). 
  • Interventions for branch retinal vein occlusion: an evidence-based systematic review. 
  • Intracanalicular Dexamethasone Insert or Topical Prednisolone Following iStent and Hydrus Surgery for Glaucoma. 
  • Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial. 
  • Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies. 
  • Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology. 
  • Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results. 
  • Intravitreal aflibercept for diabetic macular edema. 
  • Intravitreal bevacizumab for macular edema due to central retinal vein occlusion: perfused vs. ischemic and early vs. late treatment. 
  • Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. 
  • Intravitreal tissue plasminogen activator for the treatment of central retinal vein occlusion. 
  • Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. 
  • Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. 
  • Intravitreal triamcinolone for cystoid macular edema related to branch retinal vein occlusion. 
  • Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial. 
  • Is diabetic retinopathy related to subclinical cardiovascular disease? 
  • Ischemic central retinal vein occlusion and retinitis pigmentosa: lower risk of neovascularization? 
  • Lightning maculopathy. A case report. 
  • Lipids and diabetic retinopathy. 
  • Localized changes in retinal vessel caliber after focal/grid laser treatment in patients with diabetic macular edema: a measure of treatment response? 
  • Longer axial length is protective of diabetic retinopathy and macular edema. 
  • Macular features from spectral-domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. 
  • Management of diabetic retinopathy: a systematic review. 
  • Morphological characteristics of early- versus late-onset macular edema in preterm infants. 
  • Mystery of changing choroidal thickness. 
  • Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies. 
  • Neuroretinal Imaging Inflammatory Biomarkers Anticipating Radiation-Induced Macular Edema. 
  • OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE. 
  • Observational study of subclinical diabetic macular edema. 
  • Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. 
  • Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac. 
  • Ophthalmic Manifestations of ROSAH (Retinal Dystrophy, Optic Nerve Edema, Splenomegaly, Anhidrosis, and Headache) Syndrome, an Inherited NF κB-Mediated Autoinflammatory Disease with Retinal Dystrophy. 
  • Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema. 
  • Optical coherence tomography following photodynamic therapy with verteporfin for subfoveal predominantly classic choroidal neovascularization. 
  • Optical coherence tomography in retinopathy of prematurity: looking beyond the vessels. 
  • Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. 
  • Optical coherence tomography of choroidal nevus in 120 patients. 
  • Optical coherence tomography to detect macular edema in the presence of asteroid hyalosis. 
  • Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results. 
  • Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. 
  • Pars plana vitrectomy and internal limiting membrane peeling in an eye with foveal lipid deposition after focal laser surgery for diabetic macular edema. 
  • Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion. 
  • Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial. 
  • Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma. 
  • Periocular triamcinolone for prevention of macular edema after plaque radiotherapy of uveal melanoma: a randomized controlled trial. 
  • Peripheral retinal vascular leakage demonstrated by ultra-widefield fluorescein angiography in preeclampsia with HELLP syndrome. 
  • Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema. 
  • Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema. 
  • Poorer neurodevelopmental outcomes associated with cystoid macular edema identified in preterm infants in the intensive care nursery. 
  • Positioning the obese or large-breasted patient for macular laser photocoagulation. 
  • Potential pitfalls from variable optical coherence tomograph displays in managing diabetic macular edema. 
  • Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial. 
  • Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. 
  • Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. 
  • Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results. 
  • Quantification of retinal microvasculature and neurodegeneration changes in branch retinal vein occlusion after resolution of cystoid macular edema on optical coherence tomography angiography. 
  • Quantitative measurement of hard exudates in patients with diabetes and their associations with serum lipid levels. 
  • RECONSTITUTION OF THE ELLIPSOID ZONE WITH TOCILIZUMAB IN AUTOIMMUNE RETINOPATHY. 
  • Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. 
  • Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema. 
  • Rare Complication of Sclerochoroidal Calcifications. 
  • Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. 
  • Re: Saksens et al.: Dominant cystoid macular dystrophy (Ophthalmology 2015;122:180-91). 
  • Reading speed improvements in retinal vein occlusion after ranibizumab treatment. 
  • Reduced fluorescein angiography and fundus photography use in the management of neovascular macular degeneration and macular edema during the past decade. 
  • Region-specific ischemia, neovascularization and macular oedema in treatment-naïve proliferative diabetic retinopathy. 
  • Regional patterns of sight-threatening diabetic macular edema. 
  • Relationship between diabetic retinopathy, diabetic macular oedema and erectile dysfunction in type 2 diabetics. 
  • Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. 
  • Relationship of systemic endothelial function and peripheral arterial stiffness with diabetic retinopathy. 
  • Reply. 
  • Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema. 
  • Resolution of advanced cystoid macular edema following photodynamic therapy for choroidal hemangioma. 
  • Resolution of exudative retinal detachment from retinal astrocytoma following photodynamic therapy. 
  • Resource use and costs associated with diabetic macular edema in elderly persons. 
  • Results of peripheral laser photocoagulation in pars planitis. 
  • RetiFluidNet: A Self-Adaptive and Multi-Attention Deep Convolutional Network for Retinal OCT Fluid Segmentation. 
  • Retinal Imaging of Infants on Spectral Domain Optical Coherence Tomography. 
  • Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema. 
  • Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. 
  • Reversible retinal edema in an infant with neonatal hemochromatosis and liver failure. 
  • Role of Disorganization of Retinal Inner Layers as an Optical Coherence Tomography Biomarker in Diabetic and Uveitic Macular Edema. 
  • SARILUMAB FOR RECALCITRANT CYSTOID MACULAR EDEMA IN NON-PARANEOPLASTIC AUTOIMMUNE RETINOPATHY. 
  • SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design. 
  • SCORE Study report 3: study design and baseline characteristics. 
  • Sector laser photocoagulation for the prevention of macular edema after plaque radiotherapy for uveal melanoma: a pilot study. 
  • Sequential Sterile Intraocular Inflammation Associated With Consecutive Intravitreal Injections of Aflibercept and Ranibizumab. 
  • Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results. 
  • Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity. 
  • Targeting the Effect of VEGF in Diabetic Macular Edema. 
  • Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy. 
  • The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy. 
  • The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. 
  • The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. 
  • The impact of macular edema on visual function in intermediate, posterior, and panuveitis. 
  • The importance of fluorescein angiography in planning laser treatment of diabetic macular edema. 
  • The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. 
  • The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. 
  • The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. 
  • The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy. 
  • The role of vitrectomy surgery in diabetic macular edema. 
  • The variation in optical coherence tomography-measured macular thickness in diabetic eyes without clinical macular edema. 
  • Therapies for Macular Edema Associated with Branch Retinal Vein Occlusion: A Report by the American Academy of Ophthalmology. 
  • Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. 
  • Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant. 
  • Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2. 
  • Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial. 
  • Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis. 
  • Vitrectomy for diabetic macular edema. 
• 

  Keywords of People

  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • Farsiu, Sina, Professor in the Department of Biomedical Engineering, Electrical and Computer Engineering
  • Fekrat, Sharon, Professor of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery
  • Mruthyunjaya, Prithvi, Adjunct Associate Professor in the Department of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Toth, Cynthia Ann, Joseph A.C. Wadsworth Distinguished Professor of Ophthalmology, Biomedical Engineering